PGDx receives updated Medicare rate for Elio test

2022 01 10 23 10 0651 Lab Test Tube Dna Blood 400

Personal Genome Diagnostics (PGDx) announced an updated Medicare reimbursement rate for the Elio tissue complete test, a comprehensive genomic profiling test for patients living with advanced cancers.

The Centers for Medicare & Medicaid Services finalized a national reimbursement rate of $2,919.60 for the proprietary laboratory analyses code (0250U) that PGDx obtained for the test, the company reported in a release.

The new Medicare payment rate went into effect on January 1, 2022, and more information can be found on the CMS lab fee schedule webpage.

Page 1 of 5
Next Page